1 Result(s)

Article

Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells

Doxorubicin (DOX) is considered one of the most powerful chemotherapeutic agents but its clinical use has several limitations, including cardiomyopathy and cellular resistance to the drug. By using transferrin...

Paulina Wigner, Krzysztof Zielinski, Magdalena Labieniec-Watala… in Scientific Reports (2021)